VYRIAD
Vyriad, Inc.
Mark For: VYRIAD™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 98122765 |
| Mark Literal Elements | VYRIAD |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark, Service Mark |
| Current Location | NEW APPLICATION PROCESSING 2023-08-11 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | Yes |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Michelle L. Zimmermann |
| Attorney Docket Number | 291900 |
Timeline
| 2016-10-26 | Date of First Use |
| 2016-10-26 | Date of Use In Commerce |
| 2023-08-08 | Application Filed |
| 2023-08-11 | Location: NEW APPLICATION PROCESSING |
| 2023-08-11 | Status: Live/Pending |
| 2023-08-11 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
| 2023-08-11 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Vyriad, Inc. |
| Address | Building 110 2900 37th Street NW Rochester, MINNESOTA UNITED STATES 55901 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2023-08-08 | |
| Drawing | 2023-08-08 | |
| Specimen | 2023-08-08 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals, namely, bio-pharmaceuticals for the treatment of cancer; stem cells for medical use; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for providing stem cell therapy; cellular pharmaceutical preparations for use in oncology and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for medical use; pharmaceutical preparations for use in oncology |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NEW APPLICATION ENTERED | 2023-08-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 